Logo preloader

DEFEAT CANCER

NETRIS Pharma is dedicated to defeat cancer through novel and unique approach targeting Netrin-1
visuel information

Best-in-Class Environment to foster Therapeutic Innovation

NETRIS Pharma is the first spin-off of Centre Léon Bérard and the Cancer Research Center of Lyon – CRCL – (Lyon, France) and benefits from the exceptional environment of this world’s renowned comprehensive center dedicated to cancer care, education and research.

IMG_0243 recadré4
visuel information

Innovative Therapeutic Approach

By developing therapeutic products targeting a novel mechanism of cancer resistance, we offer patients new solutions alleviating resistance to chemotherapy, targeted therapy and immunotherapy.

IMG_0484 IMG_0382
Generated with Avocode.Picto-ampoule-cadenasRectanglePicto-ampoule-cadenasShapeShapePath
Strategic Focus on Intellectual Property Rights

As the world pioneer and leader biopharmaceutical company targeting netrin-1 and ligands of Dependence Receptors, NETRIS Pharma is building a unique portfolio of worldwide exclusive rights and patents on all key elements of its approach.

Our partners

NETRIS Pharma has grown from inception with the full support of Research, Clinical and Corporate Partners.

Clinical
Corporate
Research
Logo-centre-leon-bernard
Logo-HCL
Logo-CHU-Grenoble-Alpes
Logo-Arcagy_gineco
Logo-bpi-france
Logo-région-Auvergne-Rhône-Alpes
Logo-Lyon-Biopole-AURA
Logo-union-européenne
eurekaEurostars
Logo-CLARA
Logo-Inserm
Logo-Université-Lyon-1
anr-logo
Logo-CNRS
Logo-Université-Lyon
CRCL